Purpose: A randomized controlled trial (UMIN-CTR 000003469) was conducted to evaluate the superiority of peritoneovenous shunt over other treatments for refractory ascites in patients with advanced cancer.
No takes yet. Share an insight, caveat, or question.
Arai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: